fda warning letters bpc-157 sellers Sends to Multiple Companies for Illegally Selling Adulterated Dietary Supplements FDA Issues Five Warning Letters

Final thoughts Stopping GHK-Cu typically produces gradual benefit decline over 2-4 months without dramatic rebound effects or rapid reversal to pre-treatment baseline, with 30-40% of long-term users (6+ months treatment) maintaining 50-70% of peak improvements indefinitely while shorter-term users show greater regression toward baseline

I use 26g 1 inch needles to inject and use a separate larger needle to draw up liquid from ampoules I couldn't get from usual pharmacy so purchased from here

Recommend it

At the moment, the most accurate answer is that safety has not been fully established in humans

And it is because we're a prescription first society